Targeting telomerase for cancer therapy

AN Guterres, J Villanueva - Oncogene, 2020 - nature.com
Telomere maintenance via telomerase reactivation is a nearly universal hallmark of cancer
cells which enables replicative immortality. In contrast, telomerase activity is silenced in most …

Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer

R Leão, JD Apolónio, D Lee, A Figueiredo… - Journal of biomedical …, 2018 - Springer
Background Limitless self-renewal is one of the hallmarks of cancer and is attained by
telomere maintenance, essentially through telomerase (h TERT) activation. Transcriptional …

TERT promoter mutations in telomere biology

B Heidenreich, R Kumar - Mutation Research/Reviews in Mutation …, 2017 - Elsevier
Telomere repeats at chromosomal ends, critical to genome integrity, are maintained through
an elaborate network of proteins and pathways. Shelterin complex proteins shield telomeres …

Revisiting telomere shortening in cancer

K Okamoto, H Seimiya - Cells, 2019 - mdpi.com
Telomeres, the protective structures of chromosome ends are gradually shortened by each
cell division, eventually leading to senescence or apoptosis. Cancer cells maintain the …

Emerging mechanisms of telomerase reactivation in cancer

S Sharma, S Chowdhury - Trends in cancer, 2022 - cell.com
Mutations in the promoter of human telomerase reverse transcriptase (hTERT) result in
hyperactivation of hTERT. Notably, all mutations are G> A transitions, frequently found in a …

Treating cancer by targeting telomeres and telomerase

M Ivancich, Z Schrank, L Wojdyla, B Leviskas… - Antioxidants, 2017 - mdpi.com
Telomerase is expressed in more than 85% of cancer cells. Tumor cells with metastatic
potential may have a high telomerase activity, allowing cells to escape from the inhibition of …

TERT biology and function in cancer: beyond immortalisation

A Pestana, J Vinagre… - Journal of molecular …, 2017 - jme.bioscientifica.com
Evasion of replicative senescence and proliferation without restriction, sometimes
designated as immortalisation, is one of the hallmarks of cancer that may be attained …

Treatment of acral and mucosal melanoma: Current and emerging targeted therapies

J Zhang, H Tian, L Mao, L Si - Critical Reviews in Oncology/Hematology, 2024 - Elsevier
Targeted therapies revolutionized the management of patients with advanced and
metastatic cutaneous melanoma. However, despite recent advances in the understanding of …

Activation of mutant TERT promoter by RAS-ERK signaling is a key step in malignant progression of BRAF-mutant human melanomas

Y Li, HS Cheng, WJ Chng… - Proceedings of the …, 2016 - National Acad Sciences
Although activating BRAF/NRAS mutations are frequently seen in melanomas, they are not
sufficient to drive malignant transformation and require additional events. Frequent co …

Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancer

YS Song, SK Yoo, HH Kim, G Jung… - Endocrine-related …, 2019 - erc.bioscientifica.com
Synergistic effects of BRAF V600E and TERT promoter mutations on the poor clinical
outcomes in papillary thyroid cancer (PTC) have been demonstrated. The potential …